$230.43
0.27% day before yesterday
NYSE, Dec 27, 10:10 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$230.43
-11.72 4.84% 1M
+25.53 12.46% 6M
+3.14 1.38% YTD
+3.77 1.66% 1Y
-33.14 12.57% 3Y
+84.95 58.40% 5Y
+137.31 147.45% 10Y
NYSE, Closing price Fri, Dec 27 2024
-0.63 0.27%
ISIN
US50540R4092
Symbol
LH
Sector

Key metrics

Market capitalization $19.27b
Enterprise Value $25.49b
P/E (TTM) P/E ratio 44.61
EV/FCF (TTM) EV/FCF 30.23
EV/Sales (TTM) EV/Sales 2.01
P/S ratio (TTM) P/S ratio 1.52
P/B ratio (TTM) P/B ratio 2.36
Dividend yield 1.25%
Last dividend (FY24) $2.88
Revenue growth (TTM) Revenue growth -6.13%
Revenue (TTM) Revenue $12.71b
EBIT (operating result TTM) EBIT $1.14b
Free Cash Flow (TTM) Free Cash Flow $843.20m
Cash position $1.52b
EPS (TTM) EPS $5.16
P/E forward 23.51
P/S forward 1.48
EV/Sales forward 1.96
Short interest 3.15%
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Laboratory forecast:

14x Buy
70%
6x Hold
30%

Analyst Opinions

20 Analysts have issued a Laboratory forecast:

Buy
70%
Hold
30%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
12,713 12,713
6% 6%
100%
- Direct Costs 9,409 9,409
7% 7%
74%
3,304 3,304
3% 3%
26%
- Selling and Administrative Expenses 1,545 1,545
14% 14%
12%
- Research and Development Expense - -
-
-
1,760 1,760
14% 14%
14%
- Depreciation and Amortization 623 623
19% 19%
5%
EBIT (Operating Income) EBIT 1,137 1,137
11% 11%
9%
Net Profit 436 436
34% 34%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
PRNewsWire
12 days ago
New test supports public health preparedness efforts and testing infrastructure amid multistate outbreak of H5 bird flu in poultry and dairy cows BURLINGTON, N.C. , Dec. 17, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the commercial availability of its new H5 bird flu molecular test to aid in the diagnosis of huma...
Positive
Seeking Alpha
30 days ago
For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth indicators through the growth of new locations and acquisitions, but also expected future patient demand for diagnostics. The company's main competitor/peer in this niche is Quest Diagnostics, and Labco...
Neutral
PRNewsWire
about one month ago
Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer Symposium BOSTON and BURLINGTON, N.C. , Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with Labcorp, a global leader...
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 67,000
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today